Sei Investments CO Cumberland Pharmaceuticals Inc Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$5.35 - $6.8 $5,564 - $7,072	-1,040 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.06 - $6.5 $2,696 - $3,464	-533 Reduced 33.88%	1,040 $2,000
Q4 2018 Feb 13, 2019	BUY	$5.31 - $7.0 $3,042 - $4,011	573 Added 57.3%	1,573 $4,000
Q3 2018 Nov 08, 2018	SELL	$5.5 - $6.3 $15,444 - $17,690	-2,808 Reduced 73.74%	1,000 $1,000
Q2 2018 Aug 03, 2018	BUY	$5.91 - $6.9 $2,907 - $3,394	492 Added 14.84%	3,808 $23,000
Q1 2018 May 11, 2018	BUY	$6.62 - $7.12 $4,958 - $5,332	749 Added 29.18%	3,316 $22,000
Q4 2017 Feb 08, 2018	BUY	$6.79 - $7.96 $1,425 - $1,671	210 Added 8.91%	2,567 $19,000
Q3 2017 Nov 06, 2017	BUY	$6.47 - $7.21 $15,249 - $16,993	2,357	2,357 $17,000

24.2K

200

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $18M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.